Biotech & Healthtech
AI in early drug discovery: Advantages and challenges
AI-discovered molecules have an 80-90% success rate in Phase I clinical trials, a figure substantially higher than historic industry averages, according to PubMed and Nature .
Mateo Rossi·July 19, 2026